Abstract
Background:Obtaining tissue confirmation of the underlying pathology is the gold standard for establishing the etiology of nontraumatic vertebral compression fractures. However, newer investigative modalities such as the magnetic resonance imaging (MRI) and positron emission tomography-computed tomography (PET-CT) combined potentially offer the ability to distinguish between benign and malignant lesions, thereby circumventing the need for invasive tissue diagnostic/biopsy procedures.Methods:Twenty-four patients with nontraumatic, spontaneous vertebral compression fractures were prospectively studied. After clinical evaluation, all patients underwent MRI (with/without contrast) focusing on the spinal lesion, followed by whole-body PET-CT. This was followed by fine needle aspiration cytology (FNAC) of the lesion to confirm the diagnosis. The sensitivity and specificity of MRI and PET-CT studies were calculated for benign vs. malignant lesions.Results:The sensitivity/specificity of MRI for benign lesions were 78.57%/90%, while the sensitivity/specificity values of PET-CT for benign disease were 92.8%/90% respectively. Alternatively, the sensitivity/specificity of MRI for malignant lesions were 90%/78.57%, while the sensitivity/specificity of PET-CT for malignant disease were 90%/92.8%, respectively. Furthermore, the sensitivity for diagnosing malignant lesions utilizing both studies together was 100%, but the algorithm was not specific. Additionally, the specificity for MRI and PET-CT combined was 100% for benign lesions. PET-CT also helped in monitoring responses to empirical antitubercular treatment (ATT) therapy. Of interest, FNAC was inconclusive in four cases in which PET-CT findings helped further in either obtaining a tissue diagnosis from another location or institution of empirical therapy in suspected cases of tuberculosis.Conclusions:The specificity for MRI and PET-CT combined was 100% for benign lesions. Unfortunately, the specificity for MRI and PET-CT combined was not 100% for malignant vertebral lesions, though it was sensitive. The PET-CT scan was an extremely useful tool when FNAC from the affected site proved inconclusive. It gave additional information regarding the overall extent of disease, while identifying other locations amenable to FNAC. Furthermore, in countries where tuberculosis is endemic, the empirical response to ATT therapy could be monitored utilizing PET-CT.
Highlights
Differentiating benign from malignant disease responsible for vertebral compression fractures is challenging
SNI: Spine 2013,Vol 4, Suppl 5 - A Supplement to Surgical Neurology International extremely useful tool when fine needle aspiration cytology (FNAC) from the affected site proved inconclusive. It gave additional information regarding the overall extent of disease, while identifying other locations amenable to FNAC
When magnetic resonance imaging (MRI) scans are combined with positron emission tomography and computed tomography (PET‐CT) studies, together they better specify the pathology of vertebral lesions, while the latter (PET‐CT) screens the body for lesions at other sites
Summary
Differentiating benign from malignant disease responsible for vertebral compression fractures is challenging. Magnetic resonance images (MRI) has well‐established criteria for distinguishing between benign vs malignant spinal disease, these criteria are fallible. Standardized uptake values (SUVs) of various tissues may further help differentiate benign from malignant disease. Tissue diagnosis is still considered the gold standard (e.g., utilizing fine needle aspiration cytology [FNAC]), the combined diagnostic accuracy of MRI and PET‐CT in differentiating benign from malignant disease requires further investigation. Obtaining tissue confirmation of the underlying pathology is the gold standard for establishing the etiology of nontraumatic vertebral compression fractures. Newer investigative modalities such as the magnetic resonance imaging (MRI) and positron emission tomography‐computed tomography (PET‐CT) combined potentially offer the ability to distinguish between benign and malignant lesions, thereby circumventing the need for invasive tissue diagnostic/biopsy procedures
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.